科研速递论坛

标题: Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients ... [打印本页]

作者: xiyu 时间: 2016-1-18 16:24
标题: Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients ...

题名	Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia: results of a 24 week, double-blind, randomized Phase 3 trial.
链接	https://www.ncbi.nlm.nih.gov/pubmed/25037695?dopt=Abstract

作者: pnas2009 时间: 2016-1-18 16:24
http://pan.baidu.com/s/1ge0GggV

欢迎光临科研速递论坛 (http://expaper.cn/)